2022
DOI: 10.1002/cre2.628
|View full text |Cite
|
Sign up to set email alerts
|

Pain intensity and salivary α‐amylase activity in patients following mandibular third molar surgery

Abstract: Objective: We aimed to compare the levels of pain and salivary α-amylase (SAA) in patients before and after mandibular third molar surgery.Materials and Methods: Patients were divided into asymptomatic and symptomatic groups and were then identified by the analgesic drug taken throughout the 2-week study. The visual analog scale (VAS) was employed to evaluate the severity of pain experienced by a given subject before treatment, when the anesthetic wore off, in the morning, and at night for a period of 1 week. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…[ 10 ] A positive correlation has been shown in studies between salivary a-amylase and pain level in patients who were posted for surgery before and after. [ 11 , 12 ] Studies have shown that secretory IgA (sIgA) levels may interfere with the pain experienced by the patient and it may have a negative correlation with pain. [ 13 ] Both soluble tumour necrosis factor-α receptor II (sTNF-RII) and sIgA can be a reliable salivary biomarkers for pain assessment but sTNF-RII can be more accurate in diagnosing pain in people with advanced dementia.…”
Section: Discussionmentioning
confidence: 99%
“…[ 10 ] A positive correlation has been shown in studies between salivary a-amylase and pain level in patients who were posted for surgery before and after. [ 11 , 12 ] Studies have shown that secretory IgA (sIgA) levels may interfere with the pain experienced by the patient and it may have a negative correlation with pain. [ 13 ] Both soluble tumour necrosis factor-α receptor II (sTNF-RII) and sIgA can be a reliable salivary biomarkers for pain assessment but sTNF-RII can be more accurate in diagnosing pain in people with advanced dementia.…”
Section: Discussionmentioning
confidence: 99%